NASDAQ:INM | Free Cash Flow | InMed Pharmaceuticals Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-09-30 to 2025-09-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$1.61M
2025-06-30-$1.78M
2024-09-30-$1.83M
2024-06-30-$1.03M$0.00-$1.03M
2023-09-30-$2.17M
2023-06-30-$657,934.00
2022-09-30-$2.26M
2022-06-30-$4.05M$0.00-$4.05M
2021-09-30-$2.65M$250,000.00-$2.9M
2021-06-30-$2.01M
2020-09-30-$1.37M
2020-06-30-$1.4M-$923.00-$1.4M
2019-09-30-$2.37M$32,530.00-$2.4M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-06-30-$7.77M
2024-06-30-$6.99M$9,293.00-$7M
2023-06-30-$7.28M$160,014.00-$7.44M
2022-06-30-$15.58M$39,108.00-$15.62M
2021-06-30-$9.79M$1,725.00-$9.79M
2020-06-30-$7.37M$42,573.00-$7.42M